The University of Colorado School of Medicine is the medical school of the University of Colorado system. It is located at the Anschutz Medical Campus in Aurora, Colorado, one of the four University of Colorado campuses, six miles east of downtown Denver at the junction of Interstate 225 and Colfax Avenue.

During the past decade, University of Colorado School of Medicine conducted 53 clinical trials. In the 10-year time frame, 53 clinical trials started and 16 clinical trials were completed, i.e. on average, 30.2% percent of trials that started reached the finish line to date. In the past 5 years, 21 clinical trials started and 14 clinical trials were completed. i.e. 66.7% of trials that started reached the finish line.

Out of the total clinical trials conducted in "University of Colorado School of Medicine" #1 sponsor was "University of Colorado, Denver" with 18 trials, followed by "Eli Lilly and Company" with 4 trials sponsored, "Ferring Pharmaceuticals" with 3 trials sponsored, "Pfizer" with 3 trials sponsored and "Bristol-Myers Squibb" with 3 trials sponsored. Other sponsors include 23 different institutions and companies that sponsored additional 31 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "University of Colorado School of Medicine" #1 collaborator was "National Institute of Mental Health (NIMH)" with 2 trials as a collaborator, "National Institutes of Health (NIH)" with 2 trials as a collaborator, "University College, London" with 2 trials as a collaborator, "University of Kansas Medical Center" with 2 trials as a collaborator and "ALS Association" with 1 trials as a collaborator. Other collaborators include 22 different institutions and companies that were collaborators in the rest 32 trials.

According to Clinical.Site data, the most researched conditions in "University of Colorado School of Medicine" are "Parkinson Disease" (3 trials), "Parkinson's Disease" (3 trials), "Inclusion Body Myositis" (2 trials), "Sleep Fragmentation" (2 trials) and "Systemic Lupus Erythematosus" (2 trials). Many other conditions were trialed in "University of Colorado School of Medicine" in a lesser frequency.

Most popular intervention types in "University of Colorado School of Medicine" are "Drug" (26 trials), "Device" (10 trials), "Other" (10 trials), "Behavioral" (7 trials) and "Biological" (6 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (13 trials), "Arimoclomol" (2 trials), "0.5 mg of 13C10-retinyl-acetate" (1 trials), "3 mg zinc sulfate supplement" (1 trials) and "ADU-S100" (1 trials). Other intervention names were less common.

The vast majority of trials in "University of Colorado School of Medicine" are 54 trials for "All" genders, 3 trials for "Female" genders and 1 trials for "Male" genders.

Currently, there are NaN active trials in "University of Colorado School of Medicine". undefined are not yet recruiting, 9 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in University of Colorado School of Medicine, undefined suspended trials, and 7 terminated clinical trials to date.

Out of the total trials that were conducted in University of Colorado School of Medicine, 3 "Phase 1" clinical trials were conducted, 15 "Phase 2" clinical trials and 11 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 19 trials that are defined as “Not Applicable".